Drug intelligence / Profile preview

Free Thyroxine

Development stage: Unknown
Administration: Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Sublingual, Transdermal, Intranasal

Overview

Free thyroxine (FT4) is the unbound, biologically active form of thyroxine (T4), a crucial hormone produced by the thyroid gland. It plays a fundamental role in regulating the body's metabolic rate, growth, and development. FT4 levels are a key diagnostic marker used to assess thyroid function and diagnose various thyroid disorders, including hypothyroidism and hyperthyroidism. While FT4 itself is an endogenous hormone, its synthetic counterpart, levothyroxine, is a pharmaceutical drug used for thyroid hormone replacement therapy.

Other names: 甲状腺素

Targets

THRB (Thyroid hormone receptor beta)THRA (Thyroid hormone receptor alpha)

Beyond the preview

Go deeper on Free Thyroxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free Thyroxine.

Explore the full profile